51089-99-7 Usage
Chemical structure
An amine with a butyl chain and a 3-chlorophenyl group attached to the amino group.
The compound has an amine functional group (NH2) connected to a butyl chain (C4H9) and a 3-chlorophenyl group (C6H4Cl), which influences its chemical and biological properties.
Applications
Organic synthesis and pharmaceutical research.
The compound is commonly used in the synthesis of various organic compounds and is also utilized in pharmaceutical research for the development of new drugs.
Precursor
Potential use as a precursor in the synthesis of other organic compounds.
Due to its unique structure, 1-(3-chlorophenyl)butan-1-amine can be used as a starting material for the synthesis of a wide range of other organic compounds.
Chemical properties
Influenced by the presence of the 3-chlorophenyl group.
The 3-chlorophenyl group in the compound provides specific chemical properties that make it useful for various applications in the field of chemistry.
Biological properties
Influenced by the presence of the 3-chlorophenyl group.
The 3-chlorophenyl group also contributes to the biological properties of the compound, making it a valuable tool in pharmacology and drug development.
Industrial and research applications
Potential for various uses in the chemical and pharmaceutical industries.
Due to its specific structure and properties, 1-(3-chlorophenyl)butan-1-amine has the potential for a wide range of applications in both industrial and research settings.
Check Digit Verification of cas no
The CAS Registry Mumber 51089-99-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,0,8 and 9 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 51089-99:
(7*5)+(6*1)+(5*0)+(4*8)+(3*9)+(2*9)+(1*9)=127
127 % 10 = 7
So 51089-99-7 is a valid CAS Registry Number.
51089-99-7Relevant articles and documents
PYRAZINE-BASED TUBULIN INHIBITORS
-
Page 35, (2010/02/07)
A compound of general formula (I) or pharmaceutically acceptable prodrugs, salts, hydrates, solvates, crystal forms or diastereomers thereof is described. A method of treating a hyperproliferation-related disease state or disorder in a subject using a compound of formula (I) is also described
